1985
DOI: 10.1016/0024-3205(85)90028-1
|View full text |Cite
|
Sign up to set email alerts
|

A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
44
0

Year Published

1991
1991
2008
2008

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 140 publications
(50 citation statements)
references
References 11 publications
6
44
0
Order By: Relevance
“…3-0.35 nM;cf. Sunahara et al, 1991) by three orders of magnitude, this antagonist has also been reported to show a 100-fold higher K B value (40 nM) against the functional (cyclase-stimulating) action of DA than that predicted from its binding constant in broken membrane preparations (Andersen et al, 1985). In addition, 1-100 M of this antagonist was required to antagonize DA-or D 1 -like agonistinduced effect in previous electrophysiological studies using rat brain slices as well as cultured neurons, while still preserving selectivity over D 2 -like antagonists (Pennartz et al, 1992;Schiffmann et al, 1995;Harvey and Lacey, 1996;Nicola et al, 1996).…”
Section: Discussionmentioning
confidence: 94%
“…3-0.35 nM;cf. Sunahara et al, 1991) by three orders of magnitude, this antagonist has also been reported to show a 100-fold higher K B value (40 nM) against the functional (cyclase-stimulating) action of DA than that predicted from its binding constant in broken membrane preparations (Andersen et al, 1985). In addition, 1-100 M of this antagonist was required to antagonize DA-or D 1 -like agonistinduced effect in previous electrophysiological studies using rat brain slices as well as cultured neurons, while still preserving selectivity over D 2 -like antagonists (Pennartz et al, 1992;Schiffmann et al, 1995;Harvey and Lacey, 1996;Nicola et al, 1996).…”
Section: Discussionmentioning
confidence: 94%
“…However, one study [49] demonstrated similar increases in reward threshold using quinpirole at doses in the same range as those at which we also observe elevations in BSR threshold, although that study did not test doses higher than 0.066 mg/kg. Apomorphine, an agonist with similar affinity for D2 and D1 receptors [50,51], also increases BSR threshold at low doses (0.01-0.1 mg/kg) and decreases threshold at higher doses (0.3-1.0 mg/kg) [52]. We observe clear increases in BSR threshold following low doses of quinpirole (0.1-0.3 mg/kg) and decreases in threshold at higher doses (1.0-10 mg/kg).…”
Section: Discussionmentioning
confidence: 99%
“…The response to SCH 23390 in 5-HT1c oocytes, unlike the responses to the other benzazepines and 5-HT, activated slowly and often required several minutes of exposure to the compound. The rate of association of SCH 23390 with the dopamine D1-receptor is relatively slow (Billard et al, 1984;Andersen et al, 1985;Niznik et al, 1986 However, SKF 77434 (100gM) and SKF 82958 (100pM) (Hyttel, 1983;Hicks et al, 1984;Ohlstein & Berkowitz, 1985;Hess et al, 1986;Bischoff et al, 1986;McQuade et al, 1988;De Keyser et al, 1989 (Sumikawa et al, 1984;Mahan et al, 1990;Sakai et al, 1990). …”
Section: S-hydroxytryptaminementioning
confidence: 99%